Chemoinformaics analysis of 24,24-DIMETHYLLANOSTA-9(11),25-DIEN-3-ONE
| Molecular Weight | 452.767 | nRot | 5 |
| Heavy Atom Molecular Weight | 400.351 | nRig | 22 |
| Exact Molecular Weight | 452.402 | nRing | 4 |
| Solubility: LogS | -6.984 | nHRing | 0 |
| Solubility: LogP | 8.224 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 88.9152 |
| nHD | 0 | BPOL | 53.0348 |
| QED | 0.38 |
| Synth | 4.832 |
| Natural Product Likeliness | 3.19 |
| NR-PPAR-gamma | 0.242 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.2 |
| Pgp-sub | 0 |
| HIA | 0.11 |
| CACO-2 | -4.987 |
| MDCK | 0.00000647 |
| BBB | 0.319 |
| PPB | 0.987636 |
| VDSS | 3.109 |
| FU | 0.0191624 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.671 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.985 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.844 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.9 |
| CYP3a4-inh | 0.389 |
| CYP3a4-sub | 0.647 |
| CL | 9.986 |
| T12 | 0.013 |
| hERG | 0.005 |
| Ames | 0.016 |
| ROA | 0.259 |
| SkinSen | 0.012 |
| Carcinogencity | 0.177 |
| EI | 0.189 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.649 |
| Antiviral | No |
| Prediction | 0.715929 |